Evaluation of the incidence and of risk factors associated with trastuzumab-associated cardiac toxicity in routine clinical practice

被引：0
|
作者：
Lemieux, J. [1 ]
Cote, M. [1 ]
Provencher, L. [1 ]
Simard, I. [1 ]
St-Pierre, C. [1 ]
Demers, E. [1 ]
机构：
[1] Univ Quebec, Affiliated Hosp Ctr, Quebec City, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
589
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Population-Level Incidence and Risk Factors for Pulmonary Toxicity Associated With Amiodarone
    Jackevicius, Cynthia Anne
    Tom, Albert
    Essebag, Vidal
    Eisenberg, Mark J.
    Rahme, Elham
    Tu, Jack Ven
    Humphries, Karin
    Behlouli, Hassan
    Pilote, Louise
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (05): : 705 - 710
  • [22] Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice
    Vasista, Anuradha
    Ryan, Luke
    Naher, Sayeda
    Moylan, Eugene
    Stockler, Martin R.
    Wilcken, Nicholas
    Kiely, Belinda E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (01) : 34 - 38
  • [23] Evaluation of Pre-treatment Risk Factors for Development of Trastuzumab Deruxtecan Associated Pneumonitis
    Ahmed, O.
    Henricks, J.
    Haddad, T.
    Ma, J.
    Esguerra, V. G.
    Wang, J.
    Wert, M. J.
    Gatti-Mays, M.
    Ho, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [24] RENAL-ARTERY STENOSIS - INCIDENCE AND ASSOCIATED RISK-FACTORS IN 1015 PATIENTS UNDERGOING ROUTINE CARDIAC-CATHETERIZATION
    HARDING, MB
    HIMMELSTEIN, SI
    HARRISON, JK
    PHILLIPS, HR
    SCHWAB, SJ
    BASHORE, TM
    CIRCULATION, 1990, 82 (04) : 586 - 586
  • [25] Clinical risk factors associated with MRSA incidence in inpatient pediatric cellulitis
    Chand, S.
    Rrapi, R.
    Gabel, C.
    Song, S.
    Shah, R.
    El Saleeby, C.
    Kroshinsky, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S77 - S77
  • [26] Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicitys
    Kostapanos, Michael S.
    Athyros, Vasilios G.
    Mikhailidis, Dimitri P.
    Elisaf, Moses S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (01) : 88 - 88
  • [27] Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity
    Attridge, Rebecca L.
    Linn, William D.
    Ryan, Laurajo
    Koeller, Jim
    Frei, Christopher R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (01) : 19 - 26
  • [28] Adjuvant trastuzumab in routine clinical practice and the impact of cardiac monitoring guidelines on treatment delivery
    Murray, L. J.
    Ramakrishnan, S.
    O'Toole, L.
    Manifold, I. H.
    Purohit, O. P.
    Coleman, R. E.
    BREAST, 2010, 19 (05): : 339 - 344
  • [29] Exploring the factors associated with hand hygiene compliance of nurses during routine clinical practice
    Korniewicz, Denise M.
    El-Masri, Maher
    APPLIED NURSING RESEARCH, 2010, 23 (02) : 86 - 90
  • [30] Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK
    Rothnie, Kieran J.
    Numbere, Beade
    Gelwicks, Steven
    Lu, Yifei
    Sharma, Raj
    Compton, Chris
    Ismaila, Afisi S.
    Quint, Jennifer K.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2673 - 2685
12345